
Coherence is a medical technology company pioneering cancer management through therapeutic neurotechnology that integrates neurobiology and AI. Their flagship product, SOMA, is a wireless, coin-sized brain-computer interface implant that continuously monitors and administers personalized bioelectronic stimulation to manage cancer internally, reducing side effects and improving quality of life. The platform enables real-time cancer progression monitoring and targeted therapy, allowing home-based care and fewer hospital visits. Coherence's approach leverages patented digital neural interfaces and AI-driven closed-loop systems to decode and modulate the body's bioelectronic signals, positioning the company at the forefront of electro-oncology with expanding clinical trials and a growing presence in the US and Australia.

Coherence is a medical technology company pioneering cancer management through therapeutic neurotechnology that integrates neurobiology and AI. Their flagship product, SOMA, is a wireless, coin-sized brain-computer interface implant that continuously monitors and administers personalized bioelectronic stimulation to manage cancer internally, reducing side effects and improving quality of life. The platform enables real-time cancer progression monitoring and targeted therapy, allowing home-based care and fewer hospital visits. Coherence's approach leverages patented digital neural interfaces and AI-driven closed-loop systems to decode and modulate the body's bioelectronic signals, positioning the company at the forefront of electro-oncology with expanding clinical trials and a growing presence in the US and Australia.